Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
Cancers|April 3, 2021
Does Very Poor Performance Status Systematically Preclude Single Agent Anti-PD-1 Immunotherapy? A Multicenter Study of 35 Consecutive PatientsValérie Gounant, Michael Duruisseaux, Ghassen Soussi, et al.
Bulletin Du Cancer|April 16, 2021
How did we take care of our older cancer patients during the first COVID-19 wave? The French experienceCarole Helissey, Djamel Ghebriou, Anatole Cessot, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 19, 2024
[<sup>18</sup>F]FDG-PET/CT atypical response patterns to immunotherapy in non-small cell lung cancer patients: long term prognosis assessment and clinical management proposalMathilde Masse, David Chardin, Pierre Tricarico, et al.
Anti-Cancer Drugs|January 9, 2015
Safety of spinal radiotherapy in metastatic cancer patients receiving bevacizumab therapy: a bi-institutional case seriesRodrigue Mbagui, Julien Langrand-Escure, Pierre Annede, et al.
Age and Ageing|February 12, 2024
Disentangling the reasons why older adults do not readily participate in cancer trials: a socio-epidemiological mixed methods approachMeoïn Hagège, Michaël Bringuier, Claudia Martinez-Tapia, et al.
Advances in Radiation Oncology|December 17, 2025
Feasibility of Very High Cumulative Equivalent Dose in 2 Gy Fraction in Locally Advanced Central/Ultracentral Nonsmall Cell Lung Cancer Treated With Conventional Chemoradiation Therapy and a Stereotactic BoostAnna Gueiderikh, Baptiste Lhomel, Renaud Schiappa, et al.
The New England Journal of Medicine|October 1, 2019
Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate CancerRonald de Wit, Johann de Bono, Cora N Sternberg, et al.
European Journal of Cancer (Oxford, England : 1990)|April 12, 2018
Efficacy of cabazitaxel rechallenge in heavily treated patients with metastatic castration-resistant prostate cancerConstance Thibault, Jean-Christophe Eymard, Alison Birtle, et al.
European Urology|May 22, 2022
The GETUG SEMITEP Trial: De-escalating Chemotherapy in Good-prognosis Seminoma Based on Fluorodeoxyglucose Positron Emission Tomography/Computed TomographyYohann Loriot, Matthieu Texier, Stéphane Culine, et al.
JTO Clinical and Research Reports|October 1, 2025
Evaluation of the Safety, Pharmacokinetics, and Antitumor Activity of Tusamitamab Ravtansine in Patients With Nonsquamous NSCLC With High or Moderate Expression of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5Anas Gazzah, Charles Ricordel, Antoine Italiano, et al.
Pageof 7